查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1942363

男性不孕症市場報告：按檢測類型、治療方法、通路、最終用戶和地區分類，2026-2034 年

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球男性不孕症治療市場規模為44億美元。 IMARC Group預測，到2034年，該市場規模將達到64億美元，2026年至2034年的複合年成長率（CAGR）為4.28%。目前，歐洲在該市場佔據領先地位。男性不孕症盛行率上升、生育年齡延遲、技術顯著進步、生活方式改變、對不孕症的認知提高以及輔助生殖技術的合法化是推動市場成長的主要因素。

全球市場成長的主要驅動力是男性不孕症的增加，而男性不孕症的增加則與生活方式的改變、壓力以及環境毒素的暴露有關。根據美國國家醫學圖書館的報告顯示，北美男性不孕症的發生率估計為4.5%至6%，而澳洲的發生率更高，約9%。東歐的發生率在8%至12%之間。 Bayasgalan等人的研究表明，只有25.6%的不孕症病例是由男性因素造成的。 Thonneau等人的另一項研究則顯示，法國有20%的不孕症病例完全是由男性因素造成的。此外，基因檢測和先進的精液分析等診斷技術的不斷進步提高了男性不孕症的診斷準確性和早期發現率。同時，人們對不孕症治療的認知不斷提高，以及輔助生殖技術（ART）的日益普及，也推動了男性不孕症市場的成長。此外，政府的支持性政策、不斷成長的醫療保健支出以及全球不孕症診所數量的增加也促進了市場擴張。

美國作為重要的區域市場脫穎而出，其主要驅動力在於生活方式干涉策略和醫療技術在解決生殖健康問題方面的廣泛應用。隨著人們對醫療保健的日益重視，男性越來越傾向於早期診斷和治療不孕症。此外，公營和私營部門為意識提升而採取的措施也在推動市場需求。同時，男性不孕症研究經費的大幅增加以及肥胖和糖尿病等與不孕症相關的慢性疾病盛行率的上升，也是推動市場成長的關鍵因素。 2024年9月17日，韋恩州立大學接受美國國立衛生研究院（NIH）308萬美元的津貼，用於研究環境因素，特別是鄰苯二甲酸酯等內分泌干擾物對男性生育能力的影響。這項研究由理查德·皮爾斯納博士領導，旨在識別與生殖結果相關的精漿生物標記物，以期改善不孕症的治療，並加深對環境健康在生殖中所起作用的理解。此外，美國男性不孕症市場佔有率的擴大，也得益於專業生育診所的普及。

男性不孕症市場趨勢：

男性不孕症呈上升趨勢

久坐的生活方式、環境污染以及高壓力水平等多種因素共同導致男性生殖問題日益增加。根據美國心理學會（APA）預測，到2023年，十分之四點八的男性將面臨較高的平均壓力水平。這些因素會對精子數量、品質和活力產生負面影響。隨著男性不孕症的盛行率日益受到重視，人們對精準診斷和有效治療方法的需求也與日俱增。越來越多的夫妻尋求醫療專家的幫助來解決這些問題，導致諮詢量和生育治療服務的使用率不斷上升。

延後生育的趨勢日益成長

社會規範的改變和日益成長的職業抱負導致了推遲生育的顯著趨勢。根據美國疾病管制與預防中心（CDC）的一項調查，2015年至2019年間，40至49歲男性中有76.5%成為了父親。然而，隨著男性老齡化的成長，他們的生育能力會下降，精子品質往往會降低，DNA碎片率也會增加。這種現像也為男性帶來了與老齡化相關的生育挑戰。因此，男性不孕症市場正面臨越來越多的老年男性對生育力保存和治療方法的需求，他們希望在晚年建立家庭。這一趨勢凸顯了針對這群獨特需求的專門干預措施的必要性。

重要的技術進步

精子DNA碎片化分析等創新技術使得精子品質的評估更加精細。磁激活細胞分選（MACS）等先進的精子分選方法也提高了受精成功率。這些技術提高了不孕症病因診斷的準確性，並為醫療專業人員提供了更廣泛的個人化治療方案選擇。隨著技術的進步，有望透過為患者提供更個人化和有效的解決方案，顯著改善治療效果，並在男性不孕症市場的發展中發揮關鍵作用。

輔助生殖技術（ART）的普及

輔助生殖技術（ART）在男性不孕症治療中的應用顯著成長，其中卵胞漿內單一精子注射（ICSI）已成為最有效的方法之一。 ICSI是一種體外受精（IVF）技術，可將單一精子直接注射到卵子中。即使在精子數量少、活力差或形態異常等嚴重的男性不孕症情況下，ICSI也能實現受精。由於其高成功率和克服自然受孕傳統障礙的能力，該方法備受關注。精子採集技術的進步，包括睪丸精子提取術（TESE）和顯微鏡下附睪精子抽吸術（MESA），顯著提高了ICSI的成功率，為無精子症患者提供了新的選擇。輔助生殖技術（ART）的廣泛應用和不斷完善，對於面臨男性不孕症挑戰的夫妻來說，在拓展生育選擇方面發揮著至關重要的作用。 2024 年，SpOvum 宣布推出 SpOvum ARTPT，這是一個先進的 AI 驅動平台，旨在促進輔助生殖技術 (ART) 領域的患者互動。

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章 全球男性不孕症市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 按測試類型分類的市場區隔

  • 精子凝集試驗
  • DNA片段化方法
  • 氧化壓力分析
  • 電腦輔助精液分析
  • 精子穿透試驗
  • 其他

第7章 按治療方法分類的市場區隔

  • 藥物治療
  • 輔助生殖技術與精索靜脈曲張手術

第8章 按分銷管道分類的市場細分

  • 醫院藥房
  • 藥房和藥品商店
  • 網路藥房

第9章 依最終用戶分類的市場細分

  • 醫院和診所
  • 不孕症治療中心
  • 研究所
  • 其他

第10章 按地區分類的市場細分

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章 價值鏈分析

第13章 波特五力分析

第14章：定價分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Andrology Solutions
    • CaerusBiotech
    • CinnaGen Co.
    • Ferring group of companies
    • Halotech DNA
    • Merck KGaA
    • MotilityCount
    • SCSA Diagnostics, Inc
    • Vitrolife
    • Zydus Healthcare Limited
Product Code: SR112026A6416

The global male infertility market size was valued at USD 4.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.4 Billion by 2034, exhibiting a CAGR of 4.28% during 2026-2034. Europe currently dominates the market. The rise in the prevalence of male infertility, emerging trend of delayed parenthood, notable technological advancements, changing lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

The global market is driven by the rising prevalence of infertility among men due to lifestyle changes, stress, and exposure to environmental toxins. According to a report by the National Library of Medicine, it has been estimated that in North America, 4.5% to 6% of the male infertility rates are seen, whereas the rate is higher in Australia, at about 9%. In the Eastern European regions, the rate ranges between 8% and 12%. Bayasgalan et al. showed that only 25.6% of infertility cases resulted from male factors. Another study by Thonneau et al. showed that 20% of cases of infertility were due exclusively to male factors in France. Along with this, continual advancements in diagnostic technologies, such as genetic testing and advanced semen analysis, are enhancing the accuracy and early detection of male infertility. Moreover, growing awareness of fertility treatments and increasing acceptance of assisted reproductive technologies (ART) further support the male infertility market growth. Besides this, favorable government initiatives, rising healthcare spending, and the proliferation of fertility clinics globally contribute to the expansion of the market.

The United States stands out as a key regional market, primarily driven by the increasing adoption of lifestyle interventions and medical advancements tailored to address reproductive health issues. The growing emphasis on proactive healthcare is encouraging men to seek early diagnosis and treatment for infertility. Apart from this, the rise of private and public sector initiatives aimed at improving reproductive health awareness is also bolstering market demand. Furthermore, a significant increase in research funding for male infertility and the growing prevalence of chronic conditions, such as obesity and diabetes, linked to infertility, are major contributors to market growth. On 17th September 2024, Wayne State University received a USD3.08 Million NIH grant to study how environmental factors, particularly exposure to endocrine-disrupting phthalates, impact male fertility. Led by Dr. Richard Pilsner, the research focuses on identifying seminal plasma biomarkers linked to reproductive outcomes, aiming to improve fertility interventions and advance understanding of environmental health's role in reproduction. Moreover, expanding access to specialized fertility clinics enhances US male infertility market share.

Male Infertility Market Trends:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high-stress levels, have collectively contributed to a rise in fertility issues among men. According to the American Psychological Association (APA), in 2023, 4.8 out of 10 men reported having a higher average level of stress. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The emerging trend of delaying parenthood gained momentum due to changing societal norms and career aspirations. According to the Centers for Disease Control and Prevention, between 2015 to 2019, 76.5% of the men aged 40-49 had fathered a child. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a rise in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis allow for a more detailed assessment of sperm quality. Advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), also improve the possibility of successful fertilization. These technologies increase precision in identifying underlying causes of infertility and offer healthcare professionals a wider range of tools to tailor treatment plans. As technology transforms, it's likely to greatly improve results and be an important player in the growth of the male infertility market by giving patients more personalized and effective solutions.

Widespread Utilization of Assisted Reproductive Technology (ART)

The utilization of assisted reproductive technology (ART) has witnessed significant growth in addressing male infertility, with intracytoplasmic sperm injection (ICSI) emerging as one of the most effective techniques. ICSI, a specific type of in vitro fertilization (IVF), comprises the direct injection of a single sperm into an egg, facilitating fertilization even in instances of significant male factor infertility, like low sperm count, inadequate motility, or abnormal morphology. This method has gained prominence due to its high success rates and its ability to overcome barriers that previously limited natural conception. Improvements in sperm retrieval methods, including testicular sperm extraction (TESE) and microsurgical epididymal sperm aspiration (MESA), have significantly increased the success of ICSI, offering options for men experiencing azoospermia. The increasing accessibility and refinement of ART procedures are playing a pivotal role in expanding reproductive options for couples facing male infertility challenges. In 2024, SpOvum announced the launch of its advanced AI-powered platform, SpOvum ARTPT, aimed at advancing patient interaction in the field of Assisted Reproductive Technology (ART).

Male Infertility Industry Segmentation:

Analysis by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

DNA fragmentation technique stands as the largest component in 2025. DNA fragmentation testing is gaining prominence as the most popular test type in the male infertility diagnostics market due to its superior ability to assess sperm quality at a molecular level. It is different from conventional semen analysis as it examines the integrity of sperm DNA, which is essential for the successful fertilization and development of an embryo. This rising trend is due to the reliability of identifying underlying causes of infertility that standard tests may fail to detect. Growing awareness of the importance of DNA integrity among healthcare providers and patients contributes further to its market demand. Technology has also advanced, making DNA fragmentation testing more accessible and efficient.

Analysis by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery leads the market in 2025. ART, which contains techniques such as IVF and ICSI, gives a couple the chance to overcome almost all types of fertility problems, including male-factor infertility. Success rates, among others with ART, have also made this a sought option. On the other hand, varicocele surgery has been one of the established surgical therapies for varicocele, which are dilated veins of the scrotum. The primary function of these veins will affect the production of sperm and quality due to its interference. Corrective varicocele surgery tends to enhance the flow of blood, which potentially can improve sperm motility and production. This procedure has demonstrated positive results in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's landscape.

Analysis by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Hospitals pharmacies lead the market in 2025. Hospitals provide a one-stop, comprehensive facility for specialized diagnostics, medical expertise, and treatment options. This makes them the ideal destination for patients who may require comprehensive evaluation, consultations by fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. They play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, they offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Analysis by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Fertility centers lead the market in 2025. These centers focus entirely on giving a comprehensive series of treatments uniquely suited to infertile men and women and to infertile couples. Fertility centers contain teams of skilled reproductive endocrinologists, urologists, and embryologists, among other experts providing diagnosis evaluations, tailor-made treatment plans, and even assisted reproductive technologies under the same roof. This is the approach, through which fertility centers operate, give an integrated kind of diagnosis, analysis, and innovative treatments for male infertility. These centers provide an ideal setting that deals with all aspects of emotional and physiological concerns related to infertility problems. The availability of current technology, latest procedures, and a complete understanding about the male reproductive health allows fertility centers to become more prominent in the choices as the most preferred option for providing guidance and achieving successful cases against male infertility.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, Europe accounted for the largest market share. The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. The changing socio-cultural dynamics have increased awareness and acceptance of fertility issues, leading to more individuals and couples opting for medical intervention. In European countries, reproductive health is also given much importance, and comprehensive healthcare coverage is provided, thus increasing the accessibility of fertility treatments to a larger population. The ageing of the population throughout the region is also contributing to the increasing demand for ART since late parenthood is becoming prevalent. Additionally, Europe's strong presence in medical research and development (R&D) enhances innovation in male infertility treatment, which attracts patients locally and internationally seeking the best option.

Key Regional Takeaways:

United States Male Infertility Market Analysis

The male infertility market in the United States is growing due to the increasing prevalence of obesity and sedentary lifestyles, which are directly impacting sperm health and fertility. According to the Centers for Disease Control and Prevention, the prevalence of obesity among adults were 40.3% between august 2021 and 2023. Moreover, the prevalence was 39.2% among men. Additionally, fertility clinics are rapidly expanding their service portfolios, integrating advanced technologies such as microfluidic sperm sorting and AI-assisted diagnostics which is augmenting the market growth. Furthermore, health insurance companies are progressively including male infertility treatments in their coverage plans thereby increasing affordability. Similarly, the rising use of anabolic steroids among athletes and bodybuilders are contributing to fertility issues, fueling demand for corrective treatments. Also, research institutions are actively investing in genetic testing to address unexplained infertility cases which is bolstering the market growth. Meanwhile, the growing social acceptance of discussing male reproductive health is encouraging more individuals to seek timely medical intervention. This, in turn, is impelling the market growth.

Asia Pacific Male Infertility Market Analysis

The male infertility market in Asia Pacific is witnessing progress with the adoption of cost-effective in-vitro fertilization procedures appropriate for middle-income families. Besides this, governments are promoting awareness campaigns emphasizing the evaluation of male fertility, as the stigma surrounding infertility places blame on women. With increasing environmental toxins and industrial pollutants in urban areas, which have been proven to decrease sperm quality, demand is building for therapeutic solutions. According to reports, in 2019, India ranked as the fifth most polluted country globally and accounted for 14 of the 20 cities with the highest PM 2.5 air pollution levels. Furthermore, the rise of medical tourism, particularly in countries such as India and Thailand, is making advanced fertility treatments accessible at competitive prices, thereby positively influencing the market.

Europe Male Infertility Market Analysis

In Europe, the market is changing with the implementation of stringent workplace health regulations to limit exposure to reproductive toxins. As per the male infertility market report, pharmaceutical companies are rolling out new medications addressing hormonal imbalances linked to infertility, supported by favorable regulatory frameworks. Additionally, lifestyle shifts, including delayed family planning and increased alcohol consumption, are escalating infertility rates, prompting a rise in medical consultations. According to the government of the UK, in 2022, 56% of adults in England consumed alcohol. Moreover, men drank more than that of women. 61% of men and 51% of women consumed alcohol across the country. Apart from this, fertility centers are using non-invasive diagnostic techniques such as high-resolution ultrasound that are patient-friendly and, therefore, act as a catalyst in the market expansion. In addition, governments in the region are funding research in cryopreservation technologies that are currently in vogue among men who delay parenting. With these factors at play, the demand in the market is going up in the region.

Latin America Male Infertility Market Analysis

The Latin America male infertility market is expanding with the rising demand for low-cost fertility treatments, making them accessible to a broader population. Moreover, increased pesticide and agrochemical exposure in rural areas is driving awareness and treatment for sperm-related issues. Furthermore, rapid urbanization is contributing to lifestyle-related fertility challenges, prompting the adoption of personalized fertility solutions. According to the Central Intelligence Agency, in 2021, 87.3% of the total population in Brazil is urbanized. Due to these, the demand for male infertility market is expanding across the region.

Middle East and Africa Male Infertility Market Analysis

The Middle East and Africa market for male fertility is growing as the socio-cultural factors that created barriers to talking about infertility are slowly coming down. The rising incidences of varicocele, which were not always diagnosed due to ignorance regarding the symptoms, are being treated through minimally invasive surgery. Climatic conditions with extreme heat also resulted in low sperm quality, leading to increased demand for sophisticated diagnostic solutions. According to the NASA Earth Observatory, on June 6, 2021, Sweihan in the UAE recorded a temperature of 51.8°C (125.2°F), marking the highest temperature ever documented in the country for the month of June.

Competitive Landscape:

According to male infertility market report, the leading players are investing in research and development (R&D) to design new and enhanced diagnostic tools, treatments, and technologies for male infertility. The innovation is focused on techniques of sperm analysis, new medication, and assisted reproductive technology to ensure improved results for the treatment. Some leading players usually engage academic institutes, research institutions, and healthcare providers to share ideas and experiences with one another in their bid to enable innovations in diagnostics and treatments for male infertility. These collaborations inspire synergistic efforts to solve complex issues with the provision of holistic solutions. In addition to this, as raising awareness about male infertility becomes important, industry leaders participate in educational activities. Online platforms, seminars, and health care professional training sessions serve as information provision mediums for them. Thus, they work toward understanding the condition and ensure appropriate interventions at the right time. Moreover, key players are involved in strategic expansion endeavors by tapping into emerging markets having rising demand for the treatment of male infertility. While expanding their reach, they ensure that a larger section of patients can access leading diagnostic and therapeutic facilities.

The report provides a comprehensive analysis of the competitive landscape in the male infertility market with detailed profiles of all major companies, including:

  • Andrology Solutions
  • CaerusBiotech
  • CinnaGen Co.
  • Ferring group of companies
  • Halotech DNA
  • Merck KGaA
  • MotilityCount
  • SCSA Diagnostics, Inc
  • Vitrolife
  • Zydus Healthcare Limited

Key Questions Answered in This Report

  • 1.How big is the male infertility market?
  • 2.What is the future outlook of the male infertility market?
  • 3.What are the key factors driving the global male infertility market?
  • 4.Which region accounts for the largest male infertility market share?
  • 5.Which are the leading companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CaerusBiotech
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 CinnaGen Co.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Ferring group of companies
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Halotech DNA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 MotilityCount
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 SCSA Diagnostics, Inc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Vitrolife
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Zydus Healthcare Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2025
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: China: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: India: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: France: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2025
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million USD), 2026-2034
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players